017 | Targeting lipogenesis promotes the synergistic effect of the selective HDAC inhibitor ITF3756 with bortezomib in colon cancer cells: Marzia Franzò1, Giovanni Pratelli1, Federica Affranchi2, Antonietta Notaro2, Michela Giuliano2, Sonia Emanuele1 | 1Department of Biomedicine, Neuroscience and Advanced Diagnostics, Biochemistry Building, University of Palermo, Italy; 2Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, University of Palermo, Italy. J Biol Res. 2026;99(s1). doi:10.4081/jbr.2026.15269